Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report  
Delayed Quote. Delayed Nyse - 07/19 04:02:17 pm
141.61 USD   -0.97%
07/18DANAHER : Profit, Sales Rise in 2Q
DJ
07/18DANAHER : 2Q Earnings Snapshot
AQ
07/18DANAHER : Reports Second Quarter 2019 Results
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Danaher : Cuts Fiscal Year Targets, Gives 2Q Outlook

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2019 | 06:45am EDT

By Kimberly Chin

Danaher has cut its full-year 2019 guidance to reflect the dilution regarding its equity offering to fund its $21.4 billion acquisition of General Electric Co.'s (GE) GE BioPharma.

For the year, Danaher now anticipates earnings of $3.34 to $3.42 a share, down from its previous forecast of $3.85 to $3.95. It expects adjusted profit of $4.72 to $4.80, a cut from its prior guidance of $4.75 to $4.85. Analysts polled by Refinitiv were expecting full-year earnings of $3.98 a share and adjusted earnings of $4.79 a share.

For the current quarter, the company projects earnings between 89 cents and 92 cents a share and adjusted earnings between $1.13 and $1.16 a share. Analysts expect earnings of 99 cents a share and adjusted earnings of $1.19 a share for the second quarter.

Shares of Danaher, which has gained 21% for the year, were mostly flat in premarket trading on low trading volumes.

Write to Kimberly Chin at kimberly.chin@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
DANAHER CORPORATION -0.97% 141.61 Delayed Quote.38.67%
GENERAL ELECTRIC COMPANY -0.20% 10.04 Delayed Quote.32.89%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER CORPORATION
07/18DANAHER : Profit, Sales Rise in 2Q
DJ
07/18DANAHER : 2Q Earnings Snapshot
AQ
07/18DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
07/18DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
07/18DANAHER : Reports Second Quarter 2019 Results
PR
06/27DANAHER : Announces New Dental Company To Be Named Envista Holdings Corporation
PR
06/27DANAHER CORPORATION : Ex-dividend day for
FA
06/18DANAHER : Schedules Second Quarter 2019 Earnings Conference Call
PR
05/30IMMUNOASSAY MARKET : Growing Demand, Analysis of Leading Players by 2024 | Bio-R..
AQ
05/23DANAHER : To Present At Bernstein Strategic Decisions Conference
PR
More news
Financials (USD)
Sales 2019 20 704 M
EBIT 2019 3 592 M
Net income 2019 2 709 M
Debt 2019 23 778 M
Yield 2019 0,47%
P/E ratio 2019 38,4x
P/E ratio 2020 32,8x
EV / Sales2019 6,06x
EV / Sales2020 5,05x
Capitalization 102 B
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 150,82  $
Last Close Price 141,61  $
Spread / Highest target 22,9%
Spread / Average Target 6,51%
Spread / Lowest Target -15,3%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Steven M. Rales Chairman
Matthew R. McGrew Chief Financial Officer
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION38.67%102 584
THERMO FISHER SCIENTIFIC28.25%117 486
INTUITIVE SURGICAL12.05%61 953
BOSTON SCIENTIFIC CORPORATION20.66%59 297
ILLUMINA0.99%43 887
ROYAL PHILIPS26.88%40 493